Last Updated: April 25, 2024 @ 9:13 am | ||
5182 | N. Gonorrhea, Chlamydia, Trichomonas, Mycoplasma Genitalium NAAT | |
Specimen: | Collect: |
Also Acceptable:
|
Submit: |
Also Acceptable:
| |
Special Handling: |
| |
Rejection Criteria: |
| |
Stability: | Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: 3 Month(s); Incubated: Unacceptable | |
Methodology: |
| |
Performed: | Mon-Fri | |
Reported: | 1-3 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | Please see report for interpretive data. The Aptima Combo 2 Assay is a qualitative nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhea (GC). The Aptima Trichomonas vaginalis Assay is qualitative nucleic acid amplification test (NAAT) for the detection of Trichomonas vaginalis. The Aptima Mycoplasma genitalium assay is an in vitro nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium. It is intended for use as an aid in the diagnosis of M. genitalium urogenital infections in male and female patients suspected of M. genitalium infection. | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.